Agenda

Saundra Jain, MA, PsyD, LPC, is an Adjunct Clinical Affiliate in the School of Nursing at The University of Texas at Austin and a psychotherapist in private practice. Dr. Jain is a co-creator of WILD 5 – A Proven Path to Wellness and co-author of The Science and Practice of Wellness: Interventions for Happiness, Enthusiasm, Resilience, and Optimism (HERO). She is the co-creator of the Psychedelics and Wellness Survey (PAWS), exploring the intersection between psychedelics and wellness. She is the co-host of the newly launched podcast Happy Human 3.0, which explores how modern humans can move beyond merely surviving 21st-century stressors and begin to flourish by integrating neuroscience, positive psychiatry, and compassionate, human-centered care.

In addition, Dr. Jain serves on the Psych Congress Steering Committee, helping guide educational priorities and identify emerging needs in mental health practice. She also teaches with Fluence Training, a leading provider of psychedelic education for mental health professionals, where she serves as faculty in their certification programs in Psychedelic Harm Reduction and Integration (PHRI) and Ketamine-Assisted Psychotherapy (KAP).

Brittany Albright, MD, MPH, is a Harvard-trained, triple board-certified psychiatrist with expertise in interventional psychiatry, addiction psychiatry, and obesity medicine. She completed her adult psychiatry residency at Massachusetts General Hospital and McLean Hospital, followed by fellowship training in Addiction Psychiatry at the Medical University of South Carolina (MUSC). She currently serves as an Affiliate Assistant Professor of Psychiatry at MUSC.

Dr. Albright is the Founder and CEO of Sweetgrass Psychiatry, South Carolina’s largest physician-owned psychiatry practice, with three locations and a multidisciplinary team of 25+ clinicians. A leader in advancing access to innovative care, Sweetgrass Psychiatry was the first practice to launch esketamine in South Carolina in 2019 and has since developed a comprehensive interventional psychiatry program incorporating esketamine, ketamine, long acting injectables, and transcranial magnetic stimulation.

Her academic work includes numerous abstracts presented at national meetings and peer-reviewed publications spanning innovative psychiatric treatments and medical education. A nationally recognized speaker and consultant, Dr. Albright serves as President of the South Carolina Psychiatric Association and holds multiple leadership roles with Psych Congress, including Co-Chair of Psych Congress Elevate. She also created the Private Practice Summit, a national educational program focused on advancing independent psychiatric practice.

Her clinical approach integrates psychodynamic psychotherapy, mentalization-based therapy, and motivational interviewing with evidence-based pharmacologic and interventional treatments. She enjoys treating patients across the spectrum of psychiatric illness, with particular interests in complex mood and psychotic disorders and substance use disorders. She is trained and certified in transcranial magnetic stimulation and psychedelic-assisted psychotherapy.

Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India. He then attended graduate school at the University of Texas School of Public Health in Houston, where he was awarded a “National Institute/Center for Disease Control Competitive Traineeship”. His research thesis focused on impact of substance abuse. He graduated from the School of Public Health in 1987 with a Masters of Public Health (MPH) degree.

Dr. Jain served a three-year residency in Psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He followed that by obtaining further specialty training, by undergoing a two-year fellowship in Child and Adolescent Psychiatry. In addition, Dr. Jain completed a postdoctoral fellowship in Research Psychiatry at the University of Texas Mental Sciences Institute, in Houston. He was awarded the “National Research Service Award” for the support of this postdoctoral fellowship.

Kevin N. Williams MS, MPAS, PA-C is the CEO and Lead Clinician at OnPoint Behavioral Health. He is a Physician Associate that specializes in Psychiatry and has a mission to provide care that is experienced, holistic, and compassionate. He holds two master degrees in Interdisciplinary Medical Sciences and Physician Assistant Studies from the University of South Florida and South University respectively. He has gained experience treating children, adolescents, and adults for the past 11 years in the areas of inpatient, outpatient, and long-term care. Kevin has 10 years of experience teaching as an Adjunct Professor at several institutions around the country. Kevin also has over 10 years in executive leadership experience and maintains a passion of educating others to lead with effective influence. He has participated in mission work abroad and has enjoyed volunteering in several organizations in the Tampa Bay community. He enjoys spending time with his family along with his hobbies of aviation and traveling abroad.

Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India. He then attended graduate school at the University of Texas School of Public Health in Houston, where he was awarded a “National Institute/Center for Disease Control Competitive Traineeship”. His research thesis focused on impact of substance abuse. He graduated from the School of Public Health in 1987 with a Masters of Public Health (MPH) degree.

Dr. Jain served a three-year residency in Psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He followed that by obtaining further specialty training, by undergoing a two-year fellowship in Child and Adolescent Psychiatry. In addition, Dr. Jain completed a postdoctoral fellowship in Research Psychiatry at the University of Texas Mental Sciences Institute, in Houston. He was awarded the “National Research Service Award” for the support of this postdoctoral fellowship.

Brooke Kempf, PMHNP-BC, is a nationally recognized psychiatric-mental health nurse practitioner and educator with nearly three decades of experience providing direct patient care and advancing evidence-based mental health services.
She began her career at Hamilton Center in Terre Haute, Indiana, where she worked as a psychiatric nurse across multiple areas of the community mental health center. Her leadership earned her the Hamilton Award for Outstanding Staff Member and helped shape an outpatient care model now used across several sites.
Brooke earned her Master of Science in Nursing from Stony Brook University and is board-certified as a Psychiatric-Mental Health Nurse Practitioner through the American Nurses Credentialing Center. Her advanced certification expanded her clinical role to include medication management and psychiatric care as an outpatient provider, inpatient hospitalist, and Chief Nursing Officer. She also played a key role in integrating psychiatric services into Wabash Valley Health Center, expanding access to care for underserved communities.
In addition to her clinical and administrative leadership, Brooke serves as adjunct faculty in the PMHNP program at Indiana University Indianapolis, where she has taught Neuro-Psychopharmacology and serves as a clinical instructor. She has contributed to program development at George Washington University and received the DAISY Award for Extraordinary Nursing Faculty. Nationally, she serves on pharmaceutical advisory boards, the Psych Congress Steering Committee, and volunteers with the American Foundation for Suicide Prevention.

Brittany Albright, MD, MPH, is a Harvard-trained, triple board-certified psychiatrist with expertise in interventional psychiatry, addiction psychiatry, and obesity medicine. She completed her adult psychiatry residency at Massachusetts General Hospital and McLean Hospital, followed by fellowship training in Addiction Psychiatry at the Medical University of South Carolina (MUSC). She currently serves as an Affiliate Assistant Professor of Psychiatry at MUSC.

Dr. Albright is the Founder and CEO of Sweetgrass Psychiatry, South Carolina’s largest physician-owned psychiatry practice, with three locations and a multidisciplinary team of 25+ clinicians. A leader in advancing access to innovative care, Sweetgrass Psychiatry was the first practice to launch esketamine in South Carolina in 2019 and has since developed a comprehensive interventional psychiatry program incorporating esketamine, ketamine, long acting injectables, and transcranial magnetic stimulation.

Her academic work includes numerous abstracts presented at national meetings and peer-reviewed publications spanning innovative psychiatric treatments and medical education. A nationally recognized speaker and consultant, Dr. Albright serves as President of the South Carolina Psychiatric Association and holds multiple leadership roles with Psych Congress, including Co-Chair of Psych Congress Elevate. She also created the Private Practice Summit, a national educational program focused on advancing independent psychiatric practice.

Her clinical approach integrates psychodynamic psychotherapy, mentalization-based therapy, and motivational interviewing with evidence-based pharmacologic and interventional treatments. She enjoys treating patients across the spectrum of psychiatric illness, with particular interests in complex mood and psychotic disorders and substance use disorders. She is trained and certified in transcranial magnetic stimulation and psychedelic-assisted psychotherapy.

Kevin N. Williams MS, MPAS, PA-C is the CEO and Lead Clinician at OnPoint Behavioral Health. He is a Physician Associate that specializes in Psychiatry and has a mission to provide care that is experienced, holistic, and compassionate. He holds two master degrees in Interdisciplinary Medical Sciences and Physician Assistant Studies from the University of South Florida and South University respectively. He has gained experience treating children, adolescents, and adults for the past 11 years in the areas of inpatient, outpatient, and long-term care. Kevin has 10 years of experience teaching as an Adjunct Professor at several institutions around the country. Kevin also has over 10 years in executive leadership experience and maintains a passion of educating others to lead with effective influence. He has participated in mission work abroad and has enjoyed volunteering in several organizations in the Tampa Bay community. He enjoys spending time with his family along with his hobbies of aviation and traveling abroad.

Brittany Albright, MD, MPH, is a Harvard-trained, triple board-certified psychiatrist with expertise in interventional psychiatry, addiction psychiatry, and obesity medicine. She completed her adult psychiatry residency at Massachusetts General Hospital and McLean Hospital, followed by fellowship training in Addiction Psychiatry at the Medical University of South Carolina (MUSC). She currently serves as an Affiliate Assistant Professor of Psychiatry at MUSC.

Dr. Albright is the Founder and CEO of Sweetgrass Psychiatry, South Carolina’s largest physician-owned psychiatry practice, with three locations and a multidisciplinary team of 25+ clinicians. A leader in advancing access to innovative care, Sweetgrass Psychiatry was the first practice to launch esketamine in South Carolina in 2019 and has since developed a comprehensive interventional psychiatry program incorporating esketamine, ketamine, long acting injectables, and transcranial magnetic stimulation.

Her academic work includes numerous abstracts presented at national meetings and peer-reviewed publications spanning innovative psychiatric treatments and medical education. A nationally recognized speaker and consultant, Dr. Albright serves as President of the South Carolina Psychiatric Association and holds multiple leadership roles with Psych Congress, including Co-Chair of Psych Congress Elevate. She also created the Private Practice Summit, a national educational program focused on advancing independent psychiatric practice.

Her clinical approach integrates psychodynamic psychotherapy, mentalization-based therapy, and motivational interviewing with evidence-based pharmacologic and interventional treatments. She enjoys treating patients across the spectrum of psychiatric illness, with particular interests in complex mood and psychotic disorders and substance use disorders. She is trained and certified in transcranial magnetic stimulation and psychedelic-assisted psychotherapy.

Saundra Jain, MA, PsyD, LPC, is an Adjunct Clinical Affiliate in the School of Nursing at The University of Texas at Austin and a psychotherapist in private practice. Dr. Jain is a co-creator of WILD 5 – A Proven Path to Wellness and co-author of The Science and Practice of Wellness: Interventions for Happiness, Enthusiasm, Resilience, and Optimism (HERO). She is the co-creator of the Psychedelics and Wellness Survey (PAWS), exploring the intersection between psychedelics and wellness. She is the co-host of the newly launched podcast Happy Human 3.0, which explores how modern humans can move beyond merely surviving 21st-century stressors and begin to flourish by integrating neuroscience, positive psychiatry, and compassionate, human-centered care.

In addition, Dr. Jain serves on the Psych Congress Steering Committee, helping guide educational priorities and identify emerging needs in mental health practice. She also teaches with Fluence Training, a leading provider of psychedelic education for mental health professionals, where she serves as faculty in their certification programs in Psychedelic Harm Reduction and Integration (PHRI) and Ketamine-Assisted Psychotherapy (KAP).

Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India. He then attended graduate school at the University of Texas School of Public Health in Houston, where he was awarded a “National Institute/Center for Disease Control Competitive Traineeship”. His research thesis focused on impact of substance abuse. He graduated from the School of Public Health in 1987 with a Masters of Public Health (MPH) degree.

Dr. Jain served a three-year residency in Psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He followed that by obtaining further specialty training, by undergoing a two-year fellowship in Child and Adolescent Psychiatry. In addition, Dr. Jain completed a postdoctoral fellowship in Research Psychiatry at the University of Texas Mental Sciences Institute, in Houston. He was awarded the “National Research Service Award” for the support of this postdoctoral fellowship.

Gregory W Mattingly, MD

Associate Clinical Professor,
Washington University School of Medicine
President, Midwest Research Group
President Elect, APSARD-
American Professional Society for ADHD and Related Disorders

Gregory W Mattingly, MD is an Associate Clinical Professor of Psychiatry and has been a Psychopharmacology Instructor for more than 20 years at The Washington University School of Medicine in St. Louis, Missouri. He earned his medical degree and completed his residency at Washington University where he received a Fulbright Scholarship.

In addition to his clinical and research practice, he has been a consultant and evaluator for both the NFL and MLB.

Dr Mattingly is the President Elect for APSARD and serves on the Scientific Program Committee for the World Federation for ADHD.

Dr. Mattingly has been a principal investigator in more than 400 clinical trials and his research has been published in numerous national and international journals.

Andrew Penn, MS, PMHNP is a Professor in the University of California, San Francisco, School of Nursing where his teaching has received the UCSF Academic Senate Distinction in Teaching Award, among other recognitions. Trained as a psychiatric/mental health nurse practitioner, he directs clinical nursing operations for Salma Health an early stage psychiatric interventional treatment clinical company. As a researcher, he has collaborated on psychedelics studies of psilocybin and MDMA in the Translational Psychedelics Research (TrPR) and the Carhart-Harris labs at UCSF. A leading voice in nursing, he is a cofounder of the Organization of Psychedelic and Entheogenic Nurses (OPENurses.org), advocating for the perspective of nurses in psychedelic therapy, he has published on psychedelics in the American Journal of Nursing, Frontiers in Psychiatry, The Journal of Humanistic Psychotherapy, and JAMA. An internationally invited speaker, he has lectured at SXSW, Aspen Health Ideas Festival, TEDx, the Singapore Ministry of Health, and Oxford University and can be found at Andrewpennnp.com.

Brooke Kempf, PMHNP-BC, is a nationally recognized psychiatric-mental health nurse practitioner and educator with nearly three decades of experience providing direct patient care and advancing evidence-based mental health services.
She began her career at Hamilton Center in Terre Haute, Indiana, where she worked as a psychiatric nurse across multiple areas of the community mental health center. Her leadership earned her the Hamilton Award for Outstanding Staff Member and helped shape an outpatient care model now used across several sites.
Brooke earned her Master of Science in Nursing from Stony Brook University and is board-certified as a Psychiatric-Mental Health Nurse Practitioner through the American Nurses Credentialing Center. Her advanced certification expanded her clinical role to include medication management and psychiatric care as an outpatient provider, inpatient hospitalist, and Chief Nursing Officer. She also played a key role in integrating psychiatric services into Wabash Valley Health Center, expanding access to care for underserved communities.
In addition to her clinical and administrative leadership, Brooke serves as adjunct faculty in the PMHNP program at Indiana University Indianapolis, where she has taught Neuro-Psychopharmacology and serves as a clinical instructor. She has contributed to program development at George Washington University and received the DAISY Award for Extraordinary Nursing Faculty. Nationally, she serves on pharmaceutical advisory boards, the Psych Congress Steering Committee, and volunteers with the American Foundation for Suicide Prevention.

Gregory W Mattingly, MD

Associate Clinical Professor,
Washington University School of Medicine
President, Midwest Research Group
President Elect, APSARD-
American Professional Society for ADHD and Related Disorders

Gregory W Mattingly, MD is an Associate Clinical Professor of Psychiatry and has been a Psychopharmacology Instructor for more than 20 years at The Washington University School of Medicine in St. Louis, Missouri. He earned his medical degree and completed his residency at Washington University where he received a Fulbright Scholarship.

In addition to his clinical and research practice, he has been a consultant and evaluator for both the NFL and MLB.

Dr Mattingly is the President Elect for APSARD and serves on the Scientific Program Committee for the World Federation for ADHD.

Dr. Mattingly has been a principal investigator in more than 400 clinical trials and his research has been published in numerous national and international journals.

Saundra Jain, MA, PsyD, LPC, is an Adjunct Clinical Affiliate in the School of Nursing at The University of Texas at Austin and a psychotherapist in private practice. Dr. Jain is a co-creator of WILD 5 – A Proven Path to Wellness and co-author of The Science and Practice of Wellness: Interventions for Happiness, Enthusiasm, Resilience, and Optimism (HERO). She is the co-creator of the Psychedelics and Wellness Survey (PAWS), exploring the intersection between psychedelics and wellness. She is the co-host of the newly launched podcast Happy Human 3.0, which explores how modern humans can move beyond merely surviving 21st-century stressors and begin to flourish by integrating neuroscience, positive psychiatry, and compassionate, human-centered care.

In addition, Dr. Jain serves on the Psych Congress Steering Committee, helping guide educational priorities and identify emerging needs in mental health practice. She also teaches with Fluence Training, a leading provider of psychedelic education for mental health professionals, where she serves as faculty in their certification programs in Psychedelic Harm Reduction and Integration (PHRI) and Ketamine-Assisted Psychotherapy (KAP).

A pioneer in the field of functional and integrative medicine, board-certified child and adult psychiatrist, James M. Greenblatt, MD, has treated patients since 1988. After receiving his medical degree and completing his psychiatry residency at George Washington University, Dr. Greenblatt completed a fellowship in child and adolescent psychiatry at Johns Hopkins Medical School.

Dr. Greenblatt has lectured internationally on the scientific evidence for nutritional interventions in psychiatry and mental illness. He is the author of several books including Finally Focused: The Breakthrough Natural Treatment Plan for ADHD, Finally Hopeful and the upcoming book The Lithium Revolution.

He is the founder of Psychiatry Redefined, an educational platform dedicated to the transformation of psychiatry, which offers online courses, educational webinars, and fellowships for professionals. Please visit www.JamesGreenblattMD.com for more information.

Brooke Kempf, PMHNP-BC, is a nationally recognized psychiatric-mental health nurse practitioner and educator with nearly three decades of experience providing direct patient care and advancing evidence-based mental health services.
She began her career at Hamilton Center in Terre Haute, Indiana, where she worked as a psychiatric nurse across multiple areas of the community mental health center. Her leadership earned her the Hamilton Award for Outstanding Staff Member and helped shape an outpatient care model now used across several sites.
Brooke earned her Master of Science in Nursing from Stony Brook University and is board-certified as a Psychiatric-Mental Health Nurse Practitioner through the American Nurses Credentialing Center. Her advanced certification expanded her clinical role to include medication management and psychiatric care as an outpatient provider, inpatient hospitalist, and Chief Nursing Officer. She also played a key role in integrating psychiatric services into Wabash Valley Health Center, expanding access to care for underserved communities.
In addition to her clinical and administrative leadership, Brooke serves as adjunct faculty in the PMHNP program at Indiana University Indianapolis, where she has taught Neuro-Psychopharmacology and serves as a clinical instructor. She has contributed to program development at George Washington University and received the DAISY Award for Extraordinary Nursing Faculty. Nationally, she serves on pharmaceutical advisory boards, the Psych Congress Steering Committee, and volunteers with the American Foundation for Suicide Prevention.

Ilan Melnick, MD, is the primary psychiatrist in two outpatient clinics in the Miami, Florida area, as well as a staff psychiatrist and Chief Medical Officer at Passageway Residences of Miami-Dade County. In addition, Dr. Melnick is a staff psychiatrist and Medical Director for Jewish Community Services and performs independent medical and psychiatric evaluations for Miami-Dade County police, fire, transit and aviation departments.

Dr. Melnick received his medical degree in Bayamon, Puerto Rico and went on to do his residency in psychiatry and fellowship in geriatric psychiatry at the University of Miami/Jackson Memorial Hospital.He continues to be involved in education as an Assistant Professor at Florida International University School of medicine. He continues to be involved in education through his role giving grand rounds at major universities and hospitals around the world.

Brittany Albright, MD, MPH, is a Harvard-trained, triple board-certified psychiatrist with expertise in interventional psychiatry, addiction psychiatry, and obesity medicine. She completed her adult psychiatry residency at Massachusetts General Hospital and McLean Hospital, followed by fellowship training in Addiction Psychiatry at the Medical University of South Carolina (MUSC). She currently serves as an Affiliate Assistant Professor of Psychiatry at MUSC.

Dr. Albright is the Founder and CEO of Sweetgrass Psychiatry, South Carolina’s largest physician-owned psychiatry practice, with three locations and a multidisciplinary team of 25+ clinicians. A leader in advancing access to innovative care, Sweetgrass Psychiatry was the first practice to launch esketamine in South Carolina in 2019 and has since developed a comprehensive interventional psychiatry program incorporating esketamine, ketamine, long acting injectables, and transcranial magnetic stimulation.

Her academic work includes numerous abstracts presented at national meetings and peer-reviewed publications spanning innovative psychiatric treatments and medical education. A nationally recognized speaker and consultant, Dr. Albright serves as President of the South Carolina Psychiatric Association and holds multiple leadership roles with Psych Congress, including Co-Chair of Psych Congress Elevate. She also created the Private Practice Summit, a national educational program focused on advancing independent psychiatric practice.

Her clinical approach integrates psychodynamic psychotherapy, mentalization-based therapy, and motivational interviewing with evidence-based pharmacologic and interventional treatments. She enjoys treating patients across the spectrum of psychiatric illness, with particular interests in complex mood and psychotic disorders and substance use disorders. She is trained and certified in transcranial magnetic stimulation and psychedelic-assisted psychotherapy.

Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India. He then attended graduate school at the University of Texas School of Public Health in Houston, where he was awarded a “National Institute/Center for Disease Control Competitive Traineeship”. His research thesis focused on impact of substance abuse. He graduated from the School of Public Health in 1987 with a Masters of Public Health (MPH) degree.

Dr. Jain served a three-year residency in Psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He followed that by obtaining further specialty training, by undergoing a two-year fellowship in Child and Adolescent Psychiatry. In addition, Dr. Jain completed a postdoctoral fellowship in Research Psychiatry at the University of Texas Mental Sciences Institute, in Houston. He was awarded the “National Research Service Award” for the support of this postdoctoral fellowship.

Kevin N. Williams MS, MPAS, PA-C is the CEO and Lead Clinician at OnPoint Behavioral Health. He is a Physician Associate that specializes in Psychiatry and has a mission to provide care that is experienced, holistic, and compassionate. He holds two master degrees in Interdisciplinary Medical Sciences and Physician Assistant Studies from the University of South Florida and South University respectively. He has gained experience treating children, adolescents, and adults for the past 11 years in the areas of inpatient, outpatient, and long-term care. Kevin has 10 years of experience teaching as an Adjunct Professor at several institutions around the country. Kevin also has over 10 years in executive leadership experience and maintains a passion of educating others to lead with effective influence. He has participated in mission work abroad and has enjoyed volunteering in several organizations in the Tampa Bay community. He enjoys spending time with his family along with his hobbies of aviation and traveling abroad.

Saundra Jain, MA, PsyD, LPC, is an Adjunct Clinical Affiliate in the School of Nursing at The University of Texas at Austin and a psychotherapist in private practice. Dr. Jain is a co-creator of WILD 5 – A Proven Path to Wellness and co-author of The Science and Practice of Wellness: Interventions for Happiness, Enthusiasm, Resilience, and Optimism (HERO). She is the co-creator of the Psychedelics and Wellness Survey (PAWS), exploring the intersection between psychedelics and wellness. She is the co-host of the newly launched podcast Happy Human 3.0, which explores how modern humans can move beyond merely surviving 21st-century stressors and begin to flourish by integrating neuroscience, positive psychiatry, and compassionate, human-centered care.

In addition, Dr. Jain serves on the Psych Congress Steering Committee, helping guide educational priorities and identify emerging needs in mental health practice. She also teaches with Fluence Training, a leading provider of psychedelic education for mental health professionals, where she serves as faculty in their certification programs in Psychedelic Harm Reduction and Integration (PHRI) and Ketamine-Assisted Psychotherapy (KAP).

Brittany Albright, MD, MPH, is a Harvard-trained, triple board-certified psychiatrist with expertise in interventional psychiatry, addiction psychiatry, and obesity medicine. She completed her adult psychiatry residency at Massachusetts General Hospital and McLean Hospital, followed by fellowship training in Addiction Psychiatry at the Medical University of South Carolina (MUSC). She currently serves as an Affiliate Assistant Professor of Psychiatry at MUSC.

Dr. Albright is the Founder and CEO of Sweetgrass Psychiatry, South Carolina’s largest physician-owned psychiatry practice, with three locations and a multidisciplinary team of 25+ clinicians. A leader in advancing access to innovative care, Sweetgrass Psychiatry was the first practice to launch esketamine in South Carolina in 2019 and has since developed a comprehensive interventional psychiatry program incorporating esketamine, ketamine, long acting injectables, and transcranial magnetic stimulation.

Her academic work includes numerous abstracts presented at national meetings and peer-reviewed publications spanning innovative psychiatric treatments and medical education. A nationally recognized speaker and consultant, Dr. Albright serves as President of the South Carolina Psychiatric Association and holds multiple leadership roles with Psych Congress, including Co-Chair of Psych Congress Elevate. She also created the Private Practice Summit, a national educational program focused on advancing independent psychiatric practice.

Her clinical approach integrates psychodynamic psychotherapy, mentalization-based therapy, and motivational interviewing with evidence-based pharmacologic and interventional treatments. She enjoys treating patients across the spectrum of psychiatric illness, with particular interests in complex mood and psychotic disorders and substance use disorders. She is trained and certified in transcranial magnetic stimulation and psychedelic-assisted psychotherapy.

Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India. He then attended graduate school at the University of Texas School of Public Health in Houston, where he was awarded a “National Institute/Center for Disease Control Competitive Traineeship”. His research thesis focused on impact of substance abuse. He graduated from the School of Public Health in 1987 with a Masters of Public Health (MPH) degree.

Dr. Jain served a three-year residency in Psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He followed that by obtaining further specialty training, by undergoing a two-year fellowship in Child and Adolescent Psychiatry. In addition, Dr. Jain completed a postdoctoral fellowship in Research Psychiatry at the University of Texas Mental Sciences Institute, in Houston. He was awarded the “National Research Service Award” for the support of this postdoctoral fellowship.

Kevin N. Williams MS, MPAS, PA-C is the CEO and Lead Clinician at OnPoint Behavioral Health. He is a Physician Associate that specializes in Psychiatry and has a mission to provide care that is experienced, holistic, and compassionate. He holds two master degrees in Interdisciplinary Medical Sciences and Physician Assistant Studies from the University of South Florida and South University respectively. He has gained experience treating children, adolescents, and adults for the past 11 years in the areas of inpatient, outpatient, and long-term care. Kevin has 10 years of experience teaching as an Adjunct Professor at several institutions around the country. Kevin also has over 10 years in executive leadership experience and maintains a passion of educating others to lead with effective influence. He has participated in mission work abroad and has enjoyed volunteering in several organizations in the Tampa Bay community. He enjoys spending time with his family along with his hobbies of aviation and traveling abroad.

Saundra Jain, MA, PsyD, LPC, is an Adjunct Clinical Affiliate in the School of Nursing at The University of Texas at Austin and a psychotherapist in private practice. Dr. Jain is a co-creator of WILD 5 – A Proven Path to Wellness and co-author of The Science and Practice of Wellness: Interventions for Happiness, Enthusiasm, Resilience, and Optimism (HERO). She is the co-creator of the Psychedelics and Wellness Survey (PAWS), exploring the intersection between psychedelics and wellness. She is the co-host of the newly launched podcast Happy Human 3.0, which explores how modern humans can move beyond merely surviving 21st-century stressors and begin to flourish by integrating neuroscience, positive psychiatry, and compassionate, human-centered care.

In addition, Dr. Jain serves on the Psych Congress Steering Committee, helping guide educational priorities and identify emerging needs in mental health practice. She also teaches with Fluence Training, a leading provider of psychedelic education for mental health professionals, where she serves as faculty in their certification programs in Psychedelic Harm Reduction and Integration (PHRI) and Ketamine-Assisted Psychotherapy (KAP).

Dr. Carbray holds her PhD (93) and Master of Science (88) degrees from Rush University, Chicago and her Bachelor of Science (87) degree from Purdue University in West Lafayette, Indiana. A Clinical Professor of Psychiatry and Nursing at the University of Illinois Chicago, she has been practicing as a Psychiatric Nurse Practitioner over 35 years. As UIC faculty, Dr. Carbray teaches course content in psychopharmacology, mood disorders, and development and therapeutic interventions with children and adolescents for students across various multidisciplinary programs. As the Director of the Pediatric Mood Disorder Clinic, Dr. Carbray leads the clinical program and multidisciplinary training and is a nationally recognized clinical expert in children and adolescents with mood disorders. Dr. Carbray holds a national reputation of excellence in serving families of children with mood disorders, and was recognized with the UIC Preceptor of the year award, the Karen Gousman Excellence in Nursing Award, the American Psychiatric Nurses Association Best Practices in an Outpatient Program for Bipolar Disorder Award, the UIC Inspire Award, the APNA Distinguished Service Award and the Susan McCabe psychopharmacology lectureship from the International Society of Psychiatric Nurses. Dr Carbray has presented her work nationally and internationally and across communities and organizations including the American Girl Company. With a particular focus on helping families to help their children with mood disorders, Dr. Carbray has engaged in programs of research that are investigating the psychopharmacology of mood disorders, neurobiology of mood disorders, and neurobiologically informed treatments and family response to childhood mood disorders.

Gregory W Mattingly, MD

Associate Clinical Professor,
Washington University School of Medicine
President, Midwest Research Group
President Elect, APSARD-
American Professional Society for ADHD and Related Disorders

Gregory W Mattingly, MD is an Associate Clinical Professor of Psychiatry and has been a Psychopharmacology Instructor for more than 20 years at The Washington University School of Medicine in St. Louis, Missouri. He earned his medical degree and completed his residency at Washington University where he received a Fulbright Scholarship.

In addition to his clinical and research practice, he has been a consultant and evaluator for both the NFL and MLB.

Dr Mattingly is the President Elect for APSARD and serves on the Scientific Program Committee for the World Federation for ADHD.

Dr. Mattingly has been a principal investigator in more than 400 clinical trials and his research has been published in numerous national and international journals.

Boarded in Psychiatry, Addiction Medicine, Forensic Psychiatry and Holistic & Integrative Medicine, Arwen Podesta MD works in Louisiana, with an office in New Orleans. She authored a book on addiction, HOOKED (available on Amazon, see her website, www.podestawellness.com). She was recently awarded the honor of distinguished fellow of the American Psychiatry Association as well as the American Society of Addiction Medicine and is the immediate past President of the Louisiana Psychiatric Medical Association. She consults to the Louisiana governor’s HOPE committee and is a member of the Attorney General’s Opioid Abatement Taskforce. She is a national speaker, she teaches, consults and is an advocate for integrative best practices for those with addiction and psychiatric needs.

Gregory W Mattingly, MD

Associate Clinical Professor,
Washington University School of Medicine
President, Midwest Research Group
President Elect, APSARD-
American Professional Society for ADHD and Related Disorders

Gregory W Mattingly, MD is an Associate Clinical Professor of Psychiatry and has been a Psychopharmacology Instructor for more than 20 years at The Washington University School of Medicine in St. Louis, Missouri. He earned his medical degree and completed his residency at Washington University where he received a Fulbright Scholarship.

In addition to his clinical and research practice, he has been a consultant and evaluator for both the NFL and MLB.

Dr Mattingly is the President Elect for APSARD and serves on the Scientific Program Committee for the World Federation for ADHD.

Dr. Mattingly has been a principal investigator in more than 400 clinical trials and his research has been published in numerous national and international journals.

A pioneer in the field of functional and integrative medicine, board-certified child and adult psychiatrist, James M. Greenblatt, MD, has treated patients since 1988. After receiving his medical degree and completing his psychiatry residency at George Washington University, Dr. Greenblatt completed a fellowship in child and adolescent psychiatry at Johns Hopkins Medical School.

Dr. Greenblatt has lectured internationally on the scientific evidence for nutritional interventions in psychiatry and mental illness. He is the author of several books including Finally Focused: The Breakthrough Natural Treatment Plan for ADHD, Finally Hopeful and the upcoming book The Lithium Revolution.

He is the founder of Psychiatry Redefined, an educational platform dedicated to the transformation of psychiatry, which offers online courses, educational webinars, and fellowships for professionals. Please visit www.JamesGreenblattMD.com for more information.

Dr. Gehrman is Professor of Psychology in the Department of Psychiatry of the University of Pennsylvania School of Medicine, and a clinical psychologist at the Philadelphia VA Medical Center. He directs the Sleep, Neurobiology and Psychopathology lab at Penn. He has an active research program exploring the mechanisms and treatment of sleep and circadian dysregulation in the context of mental health disorders. Dr. Gehrman’s clinical specialization is on the delivery of cognitive behavioral and chronotherapeutic interventions for insomnia, circadian rhythm disorders, and other sleep disorders. The overarching goal of his work is to advance the understanding of the links between sleep and mental illness through translational research that spans biology to therapeutics.

Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India. He then attended graduate school at the University of Texas School of Public Health in Houston, where he was awarded a “National Institute/Center for Disease Control Competitive Traineeship”. His research thesis focused on impact of substance abuse. He graduated from the School of Public Health in 1987 with a Masters of Public Health (MPH) degree.

Dr. Jain served a three-year residency in Psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He followed that by obtaining further specialty training, by undergoing a two-year fellowship in Child and Adolescent Psychiatry. In addition, Dr. Jain completed a postdoctoral fellowship in Research Psychiatry at the University of Texas Mental Sciences Institute, in Houston. He was awarded the “National Research Service Award” for the support of this postdoctoral fellowship.

Saundra Jain, MA, PsyD, LPC, is an Adjunct Clinical Affiliate in the School of Nursing at The University of Texas at Austin and a psychotherapist in private practice. Dr. Jain is a co-creator of WILD 5 – A Proven Path to Wellness and co-author of The Science and Practice of Wellness: Interventions for Happiness, Enthusiasm, Resilience, and Optimism (HERO). She is the co-creator of the Psychedelics and Wellness Survey (PAWS), exploring the intersection between psychedelics and wellness. She is the co-host of the newly launched podcast Happy Human 3.0, which explores how modern humans can move beyond merely surviving 21st-century stressors and begin to flourish by integrating neuroscience, positive psychiatry, and compassionate, human-centered care.

In addition, Dr. Jain serves on the Psych Congress Steering Committee, helping guide educational priorities and identify emerging needs in mental health practice. She also teaches with Fluence Training, a leading provider of psychedelic education for mental health professionals, where she serves as faculty in their certification programs in Psychedelic Harm Reduction and Integration (PHRI) and Ketamine-Assisted Psychotherapy (KAP).

Brittany Albright, MD, MPH, is a Harvard-trained, triple board-certified psychiatrist with expertise in interventional psychiatry, addiction psychiatry, and obesity medicine. She completed her adult psychiatry residency at Massachusetts General Hospital and McLean Hospital, followed by fellowship training in Addiction Psychiatry at the Medical University of South Carolina (MUSC). She currently serves as an Affiliate Assistant Professor of Psychiatry at MUSC.

Dr. Albright is the Founder and CEO of Sweetgrass Psychiatry, South Carolina’s largest physician-owned psychiatry practice, with three locations and a multidisciplinary team of 25+ clinicians. A leader in advancing access to innovative care, Sweetgrass Psychiatry was the first practice to launch esketamine in South Carolina in 2019 and has since developed a comprehensive interventional psychiatry program incorporating esketamine, ketamine, long acting injectables, and transcranial magnetic stimulation.

Her academic work includes numerous abstracts presented at national meetings and peer-reviewed publications spanning innovative psychiatric treatments and medical education. A nationally recognized speaker and consultant, Dr. Albright serves as President of the South Carolina Psychiatric Association and holds multiple leadership roles with Psych Congress, including Co-Chair of Psych Congress Elevate. She also created the Private Practice Summit, a national educational program focused on advancing independent psychiatric practice.

Her clinical approach integrates psychodynamic psychotherapy, mentalization-based therapy, and motivational interviewing with evidence-based pharmacologic and interventional treatments. She enjoys treating patients across the spectrum of psychiatric illness, with particular interests in complex mood and psychotic disorders and substance use disorders. She is trained and certified in transcranial magnetic stimulation and psychedelic-assisted psychotherapy.

Brooke Kempf, PMHNP-BC, is a nationally recognized psychiatric-mental health nurse practitioner and educator with nearly three decades of experience providing direct patient care and advancing evidence-based mental health services.
She began her career at Hamilton Center in Terre Haute, Indiana, where she worked as a psychiatric nurse across multiple areas of the community mental health center. Her leadership earned her the Hamilton Award for Outstanding Staff Member and helped shape an outpatient care model now used across several sites.
Brooke earned her Master of Science in Nursing from Stony Brook University and is board-certified as a Psychiatric-Mental Health Nurse Practitioner through the American Nurses Credentialing Center. Her advanced certification expanded her clinical role to include medication management and psychiatric care as an outpatient provider, inpatient hospitalist, and Chief Nursing Officer. She also played a key role in integrating psychiatric services into Wabash Valley Health Center, expanding access to care for underserved communities.
In addition to her clinical and administrative leadership, Brooke serves as adjunct faculty in the PMHNP program at Indiana University Indianapolis, where she has taught Neuro-Psychopharmacology and serves as a clinical instructor. She has contributed to program development at George Washington University and received the DAISY Award for Extraordinary Nursing Faculty. Nationally, she serves on pharmaceutical advisory boards, the Psych Congress Steering Committee, and volunteers with the American Foundation for Suicide Prevention.

Kevin N. Williams MS, MPAS, PA-C is the CEO and Lead Clinician at OnPoint Behavioral Health. He is a Physician Associate that specializes in Psychiatry and has a mission to provide care that is experienced, holistic, and compassionate. He holds two master degrees in Interdisciplinary Medical Sciences and Physician Assistant Studies from the University of South Florida and South University respectively. He has gained experience treating children, adolescents, and adults for the past 11 years in the areas of inpatient, outpatient, and long-term care. Kevin has 10 years of experience teaching as an Adjunct Professor at several institutions around the country. Kevin also has over 10 years in executive leadership experience and maintains a passion of educating others to lead with effective influence. He has participated in mission work abroad and has enjoyed volunteering in several organizations in the Tampa Bay community. He enjoys spending time with his family along with his hobbies of aviation and traveling abroad.

Brittany Albright, MD, MPH, is a Harvard-trained, triple board-certified psychiatrist with expertise in interventional psychiatry, addiction psychiatry, and obesity medicine. She completed her adult psychiatry residency at Massachusetts General Hospital and McLean Hospital, followed by fellowship training in Addiction Psychiatry at the Medical University of South Carolina (MUSC). She currently serves as an Affiliate Assistant Professor of Psychiatry at MUSC.

Dr. Albright is the Founder and CEO of Sweetgrass Psychiatry, South Carolina’s largest physician-owned psychiatry practice, with three locations and a multidisciplinary team of 25+ clinicians. A leader in advancing access to innovative care, Sweetgrass Psychiatry was the first practice to launch esketamine in South Carolina in 2019 and has since developed a comprehensive interventional psychiatry program incorporating esketamine, ketamine, long acting injectables, and transcranial magnetic stimulation.

Her academic work includes numerous abstracts presented at national meetings and peer-reviewed publications spanning innovative psychiatric treatments and medical education. A nationally recognized speaker and consultant, Dr. Albright serves as President of the South Carolina Psychiatric Association and holds multiple leadership roles with Psych Congress, including Co-Chair of Psych Congress Elevate. She also created the Private Practice Summit, a national educational program focused on advancing independent psychiatric practice.

Her clinical approach integrates psychodynamic psychotherapy, mentalization-based therapy, and motivational interviewing with evidence-based pharmacologic and interventional treatments. She enjoys treating patients across the spectrum of psychiatric illness, with particular interests in complex mood and psychotic disorders and substance use disorders. She is trained and certified in transcranial magnetic stimulation and psychedelic-assisted psychotherapy.

Boarded in Psychiatry, Addiction Medicine, Forensic Psychiatry and Holistic & Integrative Medicine, Arwen Podesta MD works in Louisiana, with an office in New Orleans. She authored a book on addiction, HOOKED (available on Amazon, see her website, www.podestawellness.com). She was recently awarded the honor of distinguished fellow of the American Psychiatry Association as well as the American Society of Addiction Medicine and is the immediate past President of the Louisiana Psychiatric Medical Association. She consults to the Louisiana governor’s HOPE committee and is a member of the Attorney General’s Opioid Abatement Taskforce. She is a national speaker, she teaches, consults and is an advocate for integrative best practices for those with addiction and psychiatric needs.

Andrew Penn, MS, PMHNP is a Professor in the University of California, San Francisco, School of Nursing where his teaching has received the UCSF Academic Senate Distinction in Teaching Award, among other recognitions. Trained as a psychiatric/mental health nurse practitioner, he directs clinical nursing operations for Salma Health an early stage psychiatric interventional treatment clinical company. As a researcher, he has collaborated on psychedelics studies of psilocybin and MDMA in the Translational Psychedelics Research (TrPR) and the Carhart-Harris labs at UCSF. A leading voice in nursing, he is a cofounder of the Organization of Psychedelic and Entheogenic Nurses (OPENurses.org), advocating for the perspective of nurses in psychedelic therapy, he has published on psychedelics in the American Journal of Nursing, Frontiers in Psychiatry, The Journal of Humanistic Psychotherapy, and JAMA. An internationally invited speaker, he has lectured at SXSW, Aspen Health Ideas Festival, TEDx, the Singapore Ministry of Health, and Oxford University and can be found at Andrewpennnp.com.

Saundra Jain, MA, PsyD, LPC, is an Adjunct Clinical Affiliate in the School of Nursing at The University of Texas at Austin and a psychotherapist in private practice. Dr. Jain is a co-creator of WILD 5 – A Proven Path to Wellness and co-author of The Science and Practice of Wellness: Interventions for Happiness, Enthusiasm, Resilience, and Optimism (HERO). She is the co-creator of the Psychedelics and Wellness Survey (PAWS), exploring the intersection between psychedelics and wellness. She is the co-host of the newly launched podcast Happy Human 3.0, which explores how modern humans can move beyond merely surviving 21st-century stressors and begin to flourish by integrating neuroscience, positive psychiatry, and compassionate, human-centered care.

In addition, Dr. Jain serves on the Psych Congress Steering Committee, helping guide educational priorities and identify emerging needs in mental health practice. She also teaches with Fluence Training, a leading provider of psychedelic education for mental health professionals, where she serves as faculty in their certification programs in Psychedelic Harm Reduction and Integration (PHRI) and Ketamine-Assisted Psychotherapy (KAP).

Dr. Gehrman is Professor of Psychology in the Department of Psychiatry of the University of Pennsylvania School of Medicine, and a clinical psychologist at the Philadelphia VA Medical Center. He directs the Sleep, Neurobiology and Psychopathology lab at Penn. He has an active research program exploring the mechanisms and treatment of sleep and circadian dysregulation in the context of mental health disorders. Dr. Gehrman’s clinical specialization is on the delivery of cognitive behavioral and chronotherapeutic interventions for insomnia, circadian rhythm disorders, and other sleep disorders. The overarching goal of his work is to advance the understanding of the links between sleep and mental illness through translational research that spans biology to therapeutics.

Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India. He then attended graduate school at the University of Texas School of Public Health in Houston, where he was awarded a “National Institute/Center for Disease Control Competitive Traineeship”. His research thesis focused on impact of substance abuse. He graduated from the School of Public Health in 1987 with a Masters of Public Health (MPH) degree.

Dr. Jain served a three-year residency in Psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He followed that by obtaining further specialty training, by undergoing a two-year fellowship in Child and Adolescent Psychiatry. In addition, Dr. Jain completed a postdoctoral fellowship in Research Psychiatry at the University of Texas Mental Sciences Institute, in Houston. He was awarded the “National Research Service Award” for the support of this postdoctoral fellowship.

Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India. He then attended graduate school at the University of Texas School of Public Health in Houston, where he was awarded a “National Institute/Center for Disease Control Competitive Traineeship”. His research thesis focused on impact of substance abuse. He graduated from the School of Public Health in 1987 with a Masters of Public Health (MPH) degree.

Dr. Jain served a three-year residency in Psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He followed that by obtaining further specialty training, by undergoing a two-year fellowship in Child and Adolescent Psychiatry. In addition, Dr. Jain completed a postdoctoral fellowship in Research Psychiatry at the University of Texas Mental Sciences Institute, in Houston. He was awarded the “National Research Service Award” for the support of this postdoctoral fellowship.

Andrew Penn, MS, PMHNP is a Professor in the University of California, San Francisco, School of Nursing where his teaching has received the UCSF Academic Senate Distinction in Teaching Award, among other recognitions. Trained as a psychiatric/mental health nurse practitioner, he directs clinical nursing operations for Salma Health an early stage psychiatric interventional treatment clinical company. As a researcher, he has collaborated on psychedelics studies of psilocybin and MDMA in the Translational Psychedelics Research (TrPR) and the Carhart-Harris labs at UCSF. A leading voice in nursing, he is a cofounder of the Organization of Psychedelic and Entheogenic Nurses (OPENurses.org), advocating for the perspective of nurses in psychedelic therapy, he has published on psychedelics in the American Journal of Nursing, Frontiers in Psychiatry, The Journal of Humanistic Psychotherapy, and JAMA. An internationally invited speaker, he has lectured at SXSW, Aspen Health Ideas Festival, TEDx, the Singapore Ministry of Health, and Oxford University and can be found at Andrewpennnp.com.

Boarded in Psychiatry, Addiction Medicine, Forensic Psychiatry and Holistic & Integrative Medicine, Arwen Podesta MD works in Louisiana, with an office in New Orleans. She authored a book on addiction, HOOKED (available on Amazon, see her website, www.podestawellness.com). She was recently awarded the honor of distinguished fellow of the American Psychiatry Association as well as the American Society of Addiction Medicine and is the immediate past President of the Louisiana Psychiatric Medical Association. She consults to the Louisiana governor’s HOPE committee and is a member of the Attorney General’s Opioid Abatement Taskforce. She is a national speaker, she teaches, consults and is an advocate for integrative best practices for those with addiction and psychiatric needs.

Saundra Jain, MA, PsyD, LPC, is an Adjunct Clinical Affiliate in the School of Nursing at The University of Texas at Austin and a psychotherapist in private practice. Dr. Jain is a co-creator of WILD 5 – A Proven Path to Wellness and co-author of The Science and Practice of Wellness: Interventions for Happiness, Enthusiasm, Resilience, and Optimism (HERO). She is the co-creator of the Psychedelics and Wellness Survey (PAWS), exploring the intersection between psychedelics and wellness. She is the co-host of the newly launched podcast Happy Human 3.0, which explores how modern humans can move beyond merely surviving 21st-century stressors and begin to flourish by integrating neuroscience, positive psychiatry, and compassionate, human-centered care.

In addition, Dr. Jain serves on the Psych Congress Steering Committee, helping guide educational priorities and identify emerging needs in mental health practice. She also teaches with Fluence Training, a leading provider of psychedelic education for mental health professionals, where she serves as faculty in their certification programs in Psychedelic Harm Reduction and Integration (PHRI) and Ketamine-Assisted Psychotherapy (KAP).

Dr. Carbray holds her PhD (93) and Master of Science (88) degrees from Rush University, Chicago and her Bachelor of Science (87) degree from Purdue University in West Lafayette, Indiana. A Clinical Professor of Psychiatry and Nursing at the University of Illinois Chicago, she has been practicing as a Psychiatric Nurse Practitioner over 35 years. As UIC faculty, Dr. Carbray teaches course content in psychopharmacology, mood disorders, and development and therapeutic interventions with children and adolescents for students across various multidisciplinary programs. As the Director of the Pediatric Mood Disorder Clinic, Dr. Carbray leads the clinical program and multidisciplinary training and is a nationally recognized clinical expert in children and adolescents with mood disorders. Dr. Carbray holds a national reputation of excellence in serving families of children with mood disorders, and was recognized with the UIC Preceptor of the year award, the Karen Gousman Excellence in Nursing Award, the American Psychiatric Nurses Association Best Practices in an Outpatient Program for Bipolar Disorder Award, the UIC Inspire Award, the APNA Distinguished Service Award and the Susan McCabe psychopharmacology lectureship from the International Society of Psychiatric Nurses. Dr Carbray has presented her work nationally and internationally and across communities and organizations including the American Girl Company. With a particular focus on helping families to help their children with mood disorders, Dr. Carbray has engaged in programs of research that are investigating the psychopharmacology of mood disorders, neurobiology of mood disorders, and neurobiologically informed treatments and family response to childhood mood disorders.

Gregory W Mattingly, MD

Associate Clinical Professor,
Washington University School of Medicine
President, Midwest Research Group
President Elect, APSARD-
American Professional Society for ADHD and Related Disorders

Gregory W Mattingly, MD is an Associate Clinical Professor of Psychiatry and has been a Psychopharmacology Instructor for more than 20 years at The Washington University School of Medicine in St. Louis, Missouri. He earned his medical degree and completed his residency at Washington University where he received a Fulbright Scholarship.

In addition to his clinical and research practice, he has been a consultant and evaluator for both the NFL and MLB.

Dr Mattingly is the President Elect for APSARD and serves on the Scientific Program Committee for the World Federation for ADHD.

Dr. Mattingly has been a principal investigator in more than 400 clinical trials and his research has been published in numerous national and international journals.

Boarded in Psychiatry, Addiction Medicine, Forensic Psychiatry and Holistic & Integrative Medicine, Arwen Podesta MD works in Louisiana, with an office in New Orleans. She authored a book on addiction, HOOKED (available on Amazon, see her website, www.podestawellness.com). She was recently awarded the honor of distinguished fellow of the American Psychiatry Association as well as the American Society of Addiction Medicine and is the immediate past President of the Louisiana Psychiatric Medical Association. She consults to the Louisiana governor’s HOPE committee and is a member of the Attorney General’s Opioid Abatement Taskforce. She is a national speaker, she teaches, consults and is an advocate for integrative best practices for those with addiction and psychiatric needs.